Exposure and response prevention helps adults with obsessive-compulsive disorder who do not respond to pharmacological augmentation strategies
The Journal of clinical psychiatry, 2015.
Serotonin reuptake inhibitors (SRIs) are a first-line treatment for obsessive-compulsive disorder (OCD). Yet, most patients with OCD who are taking SRIs do not show excellent response. Recent studies show that augmenting SRIs with risperidone benefits a minority of patients. We evaluated the effectiveness of exposure and response preventi...More
Full Text (Upload PDF)
PPT (Upload PPT)